Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 56,307	$ 75,502
Marketable securities	46,613	82,761
Accounts receivable and unbilled receivable, net of allowance for credit losses of $1,230 and $0, respectively	19,179	16,128
Other receivables	2,526	3,449
Inventory	866	912
Prepaid expenses and other current assets	2,401	8,360
Land held for sale	11,282	0
Total current assets	139,174	187,112
Property, plant, and equipment, net	203,919	243,118
Operating lease right-of-use asset	3,735	4,468
Intangible assets, net	73	121
Deferred tax assets	621	1,261
Other long-term assets	30,505	25,754
Total assets	378,027	461,834
Current liabilities
Accounts payable	2,921	1,858
Accrued expenses	2,779	7,689
Operating lease liabilities, current	323	367
Notes payable, short-term	3,772	1,730
Other liabilities, current	2,754	918
Derivative liability	0	300
Total current liabilities	12,549	12,862
Earnout liability	2,486	1,783
Canadian Government Research and Development Program liability	14,399	7,348
Common stock warrants liability	4,566	1,341
Notes payable, long-term	1,730	3,459
Operating lease liabilities	3,858	4,207
Other liabilities, long-term	74	8,327
Total liabilities	39,662	39,327
Commitments and contingencies (See Note 16)
STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of December 31, 2024 and 2023	0	0
Common stock, $0.0001 par value, 1,000,000,000 shares authorized; 148,574,227 and 145,706,531, issued and outstanding as of December 31, 2024 and 2023, respectively (including 3,000,000 and 4,500,000, respectively, of Sponsor Vesting Shares)	15	15
Additional paid-in capital	393,186	382,854
(Accumulated deficit) retained earnings	(38,127)	45,570
Accumulated other comprehensive loss	(16,709)	(5,932)
Total stockholders’ equity	338,365	422,507
Total liabilities and stockholders’ equity	$ 378,027	$ 461,834